Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivoKALDERON, Bella; MAYOREK, Nina; BEN-YAACOV, Limor et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 47, Num 4, pp E795-E803, issn 0193-1849Article

Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ringMOHAMMED IQBAL, A. K; KHAN, Ashraf Y; KALASHETTI, Mallikarjun B et al.European journal of medicinal chemistry. 2012, Vol 53, pp 308-315, issn 0223-5234, 8 p.Article

Synthesis of N-(5-chloro-6-(quinolin-3-yloxy)pyridin-3-yl)benzenesulfonamide derivatives as non-TZD peroxisome proliferator-activated receptor γ (PPARγ) agonistBAJARE, Swapnil; ANTHONY, Jessy; NAIR, Amrutha et al.European journal of medicinal chemistry. 2012, Vol 58, pp 355-360, issn 0223-5234, 6 p.Article

MCC-555-induced NAG-1 expression is mediated in part by KLF4CEKANOVA, Maria; LEE, Seong-Ho; MCENTEE, Michael F et al.European journal of pharmacology. 2010, Vol 637, Num 1-3, pp 30-37, issn 0014-2999, 8 p.Article

ThiazolidinedionesYKI-JÄRVINEN, Hannele.The New England journal of medicine. 2004, Vol 351, Num 11, pp 1106-1118, issn 0028-4793, 13 p.Article

Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesisGUSTAFSON, B; ELIASSON, B; SMITH, U et al.Diabetologia (Berlin). 2010, Vol 53, Num 3, pp 536-540, issn 0012-186X, 5 p.Article

Progress with thiazolidinediones in the management of type 2 diabetes mellitusMERIDEN, Terry.Clinical therapeutics. 2004, Vol 26, Num 2, pp 177-190, issn 0149-2918, 14 p.Article

Sequence variation in PPARG may underlie differential response to troglitazoneWOLFORD, Johanna K; YEATTS, Kimberly A; DHANJAL, Sharanjeet K et al.Diabetes (New York, NY). 2005, Vol 54, Num 11, pp 3319-3325, issn 0012-1797, 7 p.Article

Troglitazone : the lesson that nobody learned?GALE, Edwin A. M.Diabetologia (Berlin). 2006, Vol 49, Num 1, pp 1-6, issn 0012-186X, 6 p.Article

Visfatin is an adipokine, but it is not regulated by thiazolidinedionesHAMMARSTEDT, Ann; PIHLAJAMÄKI, Jussi; SOPASAKIS, Victoria Rotter et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 3, pp 1181-1184, issn 0021-972X, 4 p.Article

Effets antidiabétiques des thiazolidinedionesSCHEEN, André J; CHARBONNEL, Bernard.MTE. Médecine thérapeutique endocrinologie. 2001, Vol 3, Num OCT, pp 41-48, issn 1295-9359, NS2Article

Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARγ-independent mechanismARTWOHL, M; FÜRNSINN, C; WALDHÄUSL, W et al.Diabetologia (Berlin). 2005, Vol 48, Num 3, pp 586-594, issn 0012-186X, 9 p.Article

Thiazolidinediones and fluid retentionKIRYLUK, K; ISOM, R.Kidney international. 2007, Vol 72, Num 6, pp 762-768, issn 0085-2538, 7 p.Article

Synthesis and antidiabetic activity of novel 2,4-thiazolidinedione derivatives containing a thiazole ringBOZDAG-DÜNDAR, Oya; CEYLAN-ÜNLÜSOY, Meltem; VERSPOHL, Eugen J et al.Arzneimittel-Forschung. 2006, Vol 56, Num 9, pp 621-625, issn 0004-4172, 5 p.Article

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD) : study design and protocolHOME, P. D; POCOCK, S. J; BECK-NIELSEN, H et al.Diabetologia (Berlin). 2005, Vol 48, Num 9, pp 1726-1735, issn 0012-186X, 10 p.Article

CHEMISTRY OF 2,4-DIOXOTHIAZOLIDINE. VIII. SYNTHESIS OF N-ACYL DERIVATIVES OF 2,4-DIOXOTHIAZOLIDINE.PERGAL MA; POPOV PERGAL KM.1978; GLASN. KHEM. DRUSHTVA BEOGRAD; JUGOSL.; DA. 1978; VOL. 43; NO 3; PP. 13-15; ABS. SERBE; BIBL. 5 REF.Article

Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cellsKONRAD, D; RUDICH, A; BILAN, P. J et al.Diabetologia (Berlin). 2005, Vol 48, Num 5, pp 954-966, issn 0012-186X, 13 p.Article

Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 ratsCRINCOLI, Christine M; PATEL, Niti N; TCHAO, Ruy et al.Toxicology (Amsterdam). 2008, Vol 250, Num 2-3, pp 100-108, issn 0300-483X, 9 p.Article

How should postprandial glycemia be treated?CHARPENTIER, G; DARDARI, D; RIVELINE, J. P et al.Diabetes & metabolism. 2006, Vol 32, issn 1262-3636, 2S21-2S27, HS2Article

ROSIGLITAZONE WHAT WENT WRONGCOHEN, Deborah.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7772, pp 530-534, issn 1759-2151, 5 p.Article

Ineffectiveness of rosiglitazone therapy in nelson's syndromeMUNIR, A; SONG, F; INCE, P et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 5, pp 1758-1763, issn 0021-972X, 6 p.Article

Physiological Responses to Acute Psychological Stress Are Reduced by the PPARγ Agonist RosiglitazoneRYAN, Karen K; GRAYSON, Bernadette E; JONES, Kenneth R et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 3, pp 1279-1287, issn 0013-7227, 9 p.Article

Rosiglitazone, marketing, and medical scienceMOYNIHAN, Ray.BMJ. British medical journal (International ed.). 2010, Vol 340, Num 7750, pp 785-788, issn 0959-8146, 4 p.Article

Ontology-based knowledge management of troglitazone-induced hepatotoxicityHUG, Hubert; DANNECKER, Robert; SCHINDLER, Richard et al.Drug discovery today. 2004, Vol 9, Num 22, pp 948-954, issn 1359-6446, 7 p.Article

Effects of troglitazone in young first-degree Relatives of patients with type 2 diabetesLEVIN, Klaus; HOTHER-NIELSEN, Ole; HENRIKSEN, Jan Erik et al.Diabetes care. 2004, Vol 27, Num 1, pp 148-154, issn 0149-5992, 7 p.Article